Skip to content

IBM stock tanks after reporting earnings – here’s what to know

IBM stock tanks after reporting earnings - here's what to know
Dino Kurbegovic

International Business Machines (NYSE: IBM) reported quarterly earnings on July 19, garnering attention from market participants. With over 60 companies reporting earnings this week, a common thread of a strong U.S. dollar hurting the earnings now continues with IBM. 

Namely, the company posted its highest sales growth in a decade, but investors seem worried about the enterprise cutting its cash-flow estimate. The earnings highlighted revenues of $15.54 billion, a 9.3% year-on-year (YoY) increase, beating expectations by $360 million. Further, the earnings per share (EPS) were $2.31, beating estimates by $0.02.

On the flip side, the firm said that its outlook for the year would be impacted by the strength of the U.S. dollar and the company exiting from Russia. Moreover, the pain point for market participants appears to be that the company sees its free cash flow at $10 billion, which is at the lower end of an earlier projection. 

As a result, shares of IBM are sliding in pre-market trading, down over 6%, at the time of writing. 

IBM pre-market quote. Source: Nasdaq 

IBM chart and analysis 

Before the earnings announcement, the shares had been trading in the upper part of their 52-week range; however, the current pre-market drop has seemingly widened the trading range. If the drop continues, the support zone could be in the range of $129.57 to $123.95, depending on the trading volumes. 

Conversely, a resistance zone is now moved to $135.22, with the next resistance level after that at $138.22. 

IBM 20-50-200 SMA lines chart. Source. Finviz.com data. See more stocks here.

In addition, analysts rate the shares a moderate buy, with the next 12 months’ average price predictions at $147.90, 7.07% higher than the current trading price of $138.13. 

Wall Street analysts’ price targets for IBM. Source: TipRanks  

IBM has three aspects working against it: the euphoric growth seen by tech companies in 2021, which is now dying down; the rise of interest rates and a possible recession; and finally, a strong U.S. dollar that is hurting their competitiveness versus other EU and Asian companies.  

All in all, market participants will likely have to look elsewhere for robust and constant growth as in the short-term it seems as if IBM will likely have reduced growth. 

Buy stocks now with Interactive Brokers – the most advanced investment platform


Disclaimer: The content on this site should not be considered investment advice. Investing is speculative. When investing, your capital is at risk. 

Best Crypto Exchange for Intermediate Traders and Investors

  • Invest in cryptocurrencies and 3,000+ other assets including stocks and precious metals.

  • 0% commission on stocks - buy in bulk or just a fraction from as little as $10. Other fees apply. For more information, visit etoro.com/trading/fees.

  • Copy top-performing traders in real time, automatically.

  • eToro USA is registered with FINRA for securities trading.

30+ million Users
Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. Finbold.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD

Read Next:

Finance Digest

By subscribing you agree with Finbold T&C’s & Privacy Policy

Related posts

Sign Up

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

Already have an account? Sign In

Disclaimer: The information on this website is for general informational and educational purposes only and does not constitute financial, legal, tax, or investment advice. This site does not make any financial promotions, and all content is strictly informational. By using this site, you agree to our full disclaimer and terms of use. For more information, please read our complete Global Disclaimer.